| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |